Compound

Compound is a thesis-driven, research-centric venture firm based in New York City. It invests at the seed and Series A stages across deeply technical, science-driven areas. Its team of investors, researchers, and operators helps founders solve previously unsolvable technical problems, communicate their breakthroughs, and scale commercialization. The firm builds public theses through extensive research on the futures it believes in. Its focus areas include AI and robotics, biology and biotech, such as biomanufacturing and biosecurity, and crypto, including decentralized science and DePIN. Checks typically range from $400,000 to $1.5 million. Portfolio companies include Culture Biosciences, Achira, Molecule, Livepeer, and Los Angeles Project. Compound publishes ongoing research and essays across its sectors. Venture partners with domain expertise in biology, computational biology, AI, robotics, data science, and crypto work alongside the core team.